MagtraceTM and Sentimag(R) Magnetic Locatization System

Lymph Node Location System During Sentinel Biopsy Procedure

FDA Premarket Approval P160053 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for packaging magtrace vials with new replacement stoppers (i. E. , west 1358).

DeviceMagtraceTM and Sentimag(R) Magnetic Locatization System
Classification NameLymph Node Location System During Sentinel Biopsy Procedure
Generic NameLymph Node Location System During Sentinel Biopsy Procedure
ApplicantENDOMAGNETICS LTD.
Date Received2018-07-30
Decision Date2019-05-08
PMAP160053
SupplementS001
Product CodePUV
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product Yes
Applicant Address ENDOMAGNETICS LTD. the Jeffreys Building, Cowley Road cambridge CB4 O

Supplemental Filings

Supplement NumberDateSupplement Type
P160053Original Filing
S005 2022-03-24 Normal 180 Day Track
S004 2021-04-01 Normal 180 Day Track No User Fee
S003 2018-11-26 30-day Notice
S002
S001 2018-07-30 Real-time Process

NIH GUDID Devices

Device IDPMASupp
15060391210244 P160053 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.